Patient presents with moderate persistent asthma, characterized by daily symptoms requiring albuterol use, nighttime awakenings more than once per week but not nightly, and some limitation in normal activity.  Pulmonary function testing reveals FEV1 between 60% and 80% predicted, with FEV1FVC ratio reduced below the lower limit of normal.  Patient reports symptoms such as wheezing, shortness of breath, chest tightness, and cough.  Triggers identified include allergens such as dust mites, pet dander, and pollen, as well as exercise and respiratory infections.  Current medications include a daily low-dose inhaled corticosteroid.  Assessment includes review of symptom frequency and severity, lung function, and response to current therapy.  Diagnosis of moderate persistent asthma confirmed based on National Asthma Education and Prevention Program (NAEPP) guidelines.  Plan includes stepping up therapy to a medium-dose inhaled corticosteroid or adding a long-acting beta-agonist (LABA) to the current inhaled corticosteroid.  Patient education provided on asthma management, including proper inhaler technique, medication adherence, and trigger avoidance.  Follow-up scheduled in 4-6 weeks to assess response to treatment and adjust management as needed.  ICD-10 code J45.41, moderate persistent asthma, assigned.  Medical billing codes for evaluation and management, pulmonary function testing, and medications documented.